Analyst firms · Morgan Stanley · GRFS

Morgan Stanley GRFS price target and rating history

Grifols S.A. (GRFS) · Health Care

Morgan Stanley rates Grifols S.A. (GRFS) Overweight, as of its latest action on Feb 12, 2025. It has published 4 rating actions on GRFS since April 2022, including 1 upgrade and 1 downgrade.

Current rating
Overweight
Price target
Not stated
Median target, all firms
Too few
Actions on GRFS
4

Every Morgan Stanley rating on GRFS

Questions about Morgan Stanley and GRFS

What is Morgan Stanley's rating on GRFS?
Morgan Stanley rates GRFS Overweight, a bullish rating, as of Feb 12, 2025.
When did Morgan Stanley last change its view on GRFS?
On Feb 12, 2025, Morgan Stanley resumes coverage at Overweight.

All Morgan Stanley ratingsGRFS news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.